SAN FRANCISCO, and IRVINE, Calif., March 14, 2019 /PRNewswire/ — Ivantis Inc., developer of the novel Hydrus®Microstent, a device designed to lower eye pressure for open-angle glaucoma patients, announced today the 24-month results of the more »
Read More